Idenix Pharmaceuticals to Present at Deutsche Bank's 2008 Biotech Bos... ( CAMBRIDGE Mass. Nov. 7 /- IdenixP...)

Idenix Pharmaceuticals to Present at Deutsche Bank's 2008 Biotech Boston Confab

Date:11/10/2008

CAMBRIDGE, Mass., Nov. 7 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that management will present at Deutsche Bank's 2008 Biotech Boston Confab on Tuesday, November 11th at 9:40 a.m. ET.

The live and archived webcast of the presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at http://www.idenix.com. Please log in approximately 5-10 minutes before the event to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the conference.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by the hepatitis C virus and HIV. For further information about Idenix, please refer to http://www.idenix.com.

Idenix Pharmaceuticals' Contacts:

Media: Teri Dahlman (617) 995-9905

Investors: Amy Sullivan (617) 995-9838

SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:11/5/2009)...Newswire-FirstCall/ -- BioSpecifics Technologies C... developing first-in-class collagenase-based produ... third quarter ended September 30, 2009. ,, "W...year, the FDA,s Arthritis Advisory Committee unani...l of XIAFLEX(TM) for the treatment of Dupuytren,s ...

(Date:11/5/2009)... Wound Management Technol...ntered into a Letter of Intent to purchase all hea...ies, Inc. (OTC Bulletin Board: VHGI). The deal pro...ebt, 4,000,000 shares of WNDM and a royalty agreem...p technology being acquired from VHGI. WNDM clos...

(Date:11/5/2009)...RNewswire-FirstCall/ -- WaferGen Biosystems, Inc. ... state-of-the-art genetic analysis systems, today ... the company,s Scientific Advisory Board. His car...ing novel molecular diagnostics for cancer detecti...of computational biology systems for several biote...

(Date:11/5/2009)... Nov. 5 /PRNewswire-Asia-FirstCall/ -- BMP Sunston...the "Company") today announced,that the Company pl...s on,Monday, November 9, 2009, after the market cl...e call at 5:00 pm ET on November 9, 2009,to discus...s the call by,dialing 1-888-713-4211 or 1-617-213-...

Breaking Biology Technology:BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2 BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3 BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4 BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5 OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2 OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3 WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2 WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3 WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4 BMP Sunstone to Report Third Quarter 2009 Financial Results 2

[0] BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results [0] OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock [0] WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board [0] BMP Sunstone to Report Third Quarter 2009 Financial Results

... EDMONTON, Sept. 3 /PRNewswire-FirstCall/ - BioMS... treatment of multiple sclerosis (MS), announced,t...bid. Under the bid,which will be conducted pursuan..."), the Company may purchase up to 1,000,000 of it...esenting approximately 1.1% of the,Company,s issue...

.... (Nasdaq:,PLXS) announced today that it intends t...tered into an agreement to lease approximately 106...ted in Hangzhou. The new,facility will allow Plexu...ecision centers in the greater Shanghai area, and ...tal cost value proposition. This location,will be ...

...ity of Manchester who discovered the world,s thinn...work. , Professor Andre Geim FRS and Dr Kostya No...ology have been awarded the prestigious Europhysic...ubsequent work to reveal its remarkable electronic... of carbon atoms resembling chicken wire. This inc...

Other Biology Technology:BioMS Medical announces its intention to renew a normal course issuer bid 2 BioMS Medical announces its intention to renew a normal course issuer bid 3 Plexus Announces Expansion in Hangzhou, China 2 Plexus Announces Expansion in Hangzhou, China 3 Graphene pioneers follow in Nobel footsteps 2

BioMS Medical announces its intention to renew a normal course issuer bid Plexus Announces Expansion in Hangzhou, China Graphene pioneers follow in Nobel footsteps

(Date:11/3/2009)...en are as much as 28 percent less likely to become...ng to research that earned a Michigan State Univer...by Barbara Luke, a researcher in the MSU College o...ology and Reproductive Biology, focused on data of...echnology. , Luke,s findings, which also can be ...

(Date:11/3/2009)...y Samueli School of Engineering and Applied Scienc...ed in the laboratory the enzyme responsible for pr...lovastatin. , The research, published Oct. 23...to the development of other compounds with similar...esizing enzyme is one of the most interesting but ...

(Date:11/3/2009)...of Illinois at Chicago have received $1 million fr... study the relationship between "fat taxes" and fo...funding for the two-year project was made availabl...ct of 2009. , The study will link state tax rate...gar- and fat-laden foods and beverages (soda, cand...

[0] MSU researcher: Obesity significantly cuts odds of successful pregnancy [0] UCLA researchers reconstitute enzyme that synthesizes cholesterol drug lovastatin [0] UIC receives $1 million grant to study 'fat taxes,' diet, obesity

...e about how the brain assigns cells to participate...versity of Toronto team has discovered that a prot...ing a role in memory formation. The April 20 edit... a new approach for preserving memory in people su... , "Making a memory is not a conscious act," expla...

...al nervous system (CNS) in animal evolution has pu...ts and worms evolved from the same ancestor, but t...volved only after their lineages had split during ... Biology Laboratory (EMBL) in Heidelberg now revea...uch older than expected. The study, which is publi...

...tel, cancer is a metaphorical example of the perfe...regnant finch that landed on a deserted island in ...n the human body has to undergo many mutations thr...vader of different organs in the body. But once it...fferent ecological niches, cancer is tough to get ...

Other Biology News:UCLA/Toronto researchers unlock key to memory storage in brain 2 The origin of the brain lies in a worm 2 New bird, bat species revealed by extensive DNA barcode studies 2

UCLA/Toronto researchers unlock key to memory storage in brain The origin of the brain lies in a worm New bird, bat species revealed by extensive DNA barcode studies

Mouse cAMP / Ca2+ Signaling PathwayFinder, PCR Array for expression profiling from SuperArray Bioscience

Rabbit Anti-EEF2K Monoclonal Antibody, Unconjugated, Clone EP881Y from Abcam

Human Regulatory T cell (Foxp3 / CD4 / CD25) Flow Cytometry staining Kit from eBioscience

Weinreb Linker from ChemPep, Inc.

Biology Products:

Mouse cAMP / Ca2+ Signaling PathwayFinder, PCR Array for expression profiling from SuperArray Bioscience Rabbit Anti-EEF2K Monoclonal Antibody, Unconjugated, Clone EP881Y from Abcam Human Regulatory T cell (Foxp3 / CD4 / CD25) Flow Cytometry staining Kit from eBioscience Weinreb Linker from ChemPep, Inc.

Idenix Pharmaceuticals to Present at Deutsche Bank's 2008 Biotech Bos...( CAMBRIDGE Mass. Nov. 7 /- IdenixP...)